1. Temferon an ex-vivo genetically modified cell therapy aiming to fill the gaps for solid tumor immunotherapy. Issue 9 (2020) Authors: Mazzoleni, Stefania; Gentner, Bernhard; Brambilla, Valentina; Magnani, Tiziana; Ciceri, Fabio; Finocchiaro, Gaetano; , Luigi Naldini; Russo, Carlo Journal: Cell & gene therapy insights Issue: Volume 6:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗